Accounting ChangesOptimizeRx's shift in treatment of certain Medicx revenue to net, from gross, is not ideal.
Financial PerformanceOperational cash burn was reported, indicating a potential area of concern.
Revenue GuidanceOptimizeRx lowered its revenue guidance for the following year to 'at least $100M,' from a previous 'at least $110M.'